Sei sulla pagina 1di 125

Case 5:15-cv-04073-EJD Document 35-1 Filed 10/30/15 Page 1 of 125

EXHIBIT 1
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 1Page
of 11 2PageID
of 125 #: 1

IN THE UNITED STATES DISTRICT COURT


FOR THE DISTRICT OF DELAWARE

FITBIT, INC., )
)
Plaintiff, )
)
v. ) C.A. No.
)
ALIPHCOM d/b/a JAWBONE and ) DEMAND FOR JURY TRIAL
BODYMEDIA, INC., )
)
Defendants. )

COMPLAINT FOR PATENT INFRINGEMENT

Plaintiff Fitbit, Inc. (“Fitbit”), by and through its attorneys, for its complaint against

AliphCom d/b/a Jawbone and BodyMedia, Inc. (“Defendants”), hereby alleges as follows:

THE PARTIES

1. Fitbit is a Delaware corporation with its principal place of business located at 405

Howard Street, San Francisco, CA 94015.

2. On information and belief, AliphCom is a California corporation with its principal

place of business located in San Francisco, California.

3. On information and belief, BodyMedia, Inc., is a Delaware corporation with its

principal place of business located in Pittsburgh, Pennsylvania.

4. On information and belief, BodyMedia is a wholly owned subsidiary of

AliphCom.

JURISDICTION AND VENUE

5. This action for patent infringement arises under federal law, and this Court has

jurisdiction pursuant to 28 U.S.C. §§ 1331, 1338 and the Patent Laws of the United States, 35

U.S.C. § 1, et seq.
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 2Page
of 11 3PageID
of 125 #: 2

6. This Court has personal jurisdiction over Defendant AliphCom because, inter

alia, AliphCom maintains continuous and systematic contacts with this judicial district. Either

directly, or through its subsidiaries, agents, and/or affiliates, AliphCom has conducted and

continues to conduct business in this judicial district, including by manufacturing, marketing,

and selling infringing products throughout the United States and in the District of Delaware.

These acts cause injury to Fitbit within this judicial district.

7. This Court has personal jurisdiction over Defendant BodyMedia, Inc. because,

inter alia, BodyMedia is a Delaware corporation and maintains continuous and systematic

contacts with this judicial district. Either directly, or through its subsidiaries, agents, and/or

affiliates, BodyMedia has conducted and continues to conduct business in this judicial district,

including by manufacturing, marketing, and selling infringing products throughout the United

States and in the District of Delaware. These acts cause injury to Fitbit within this judicial

district.

8. Venue is proper in this court pursuant to 28 U.S.C. §§ 1391(b), (c), and 1400(b).

Defendant BodyMedia is a Delaware corporation. Defendants have committed acts of

infringement within this district, and a substantial part of the events giving rise to the claim

occurred in this District.

PATENTS-IN-SUIT

9. U.S. Patent No. 9,031,812 (the “’812 patent”), entitled “Notifications On A User

Device Based On Activity Detected By An Activity Monitoring Device,” was duly and legally

issued by the U.S. Patent and Trademark Office on May 12, 2015. The ’812 patent is assigned to

Fitbit. A true and correct copy of the ’812 patent is attached as Exhibit A.

2
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 3Page
of 11 4PageID
of 125 #: 3

10. U.S. Patent No. 8,909,543 (the “’543 patent”), entitled “Methods for Detecting

and Recording Physical Activity of Person,” was duly and legally issued by the U.S. Patent and

Trademark Office on December 9, 2014. The ’543 patent is assigned to Fitbit. A true and

correct copy of the ’543 patent is attached as Exhibit B.

11. U.S. Patent No. 9,042,971 (the “’971 patent”), entitled “Biometric Monitoring

Device With Heart Rate Measurement Activated By A Single User Gesture,” was duly and

legally issued by the U.S. Patent and Trademark Office on May 26, 2015. The ’971 patent is

assigned to Fitbit. A true and correct copy of the ’971 patent is attached as Exhibit C.

12. The ’812 patent, ’543 patent, and ’971 patent are collectively referred to herein as

the “Patents-in-Suit.” By assignment, Fitbit owns all right, title, and interest in and to the

Patents-in-Suit. Fitbit has the right to sue and recover for the infringement of the Patents-in-Suit.

BACKGROUND

13. Fitbit, Inc. is a company that helps people lead healthier, more active lives by

empowering them with data, inspiration, and guidance to reach their goals. Fitbit is an innovator

in the health and fitness market, addressing key needs with advanced technology embedded in

cutting-edge but simple-to-use products and services. Since 2007, Fitbit has pioneered the

connected health and fitness market, growing rapidly into a leading global health and fitness

brand.

14. Fitbit wearable devices track sleep and activity. The Fitbit product line includes

the Fitbit Zip, Fitbit One, Fitbit Flex, Fitbit Charge, Fitbit Charge HR, and Fitbit Surge.

15. Defendants manufacture, market, and sell activity trackers—including the UP

Move, UP24, UP2, UP3, and UP4—that infringe one or more of the Patents-in-Suit.

3
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 4Page
of 11 5PageID
of 125 #: 4

Defendants’ activity trackers are used in conjunction with the UP App, made available by

Defendants as part of the “UP System.”

16. On information and belief, AliphCom acquired BodyMedia, Inc. in April 2013

and incorporated BodyMedia’s “multi-sensor approach” to physiological data collection and

other BodyMedia technology into subsequent products. Products incorporating multiple sensors,

such as temperature sensors and bioimpedance sensors, include at least the UP3 and UP4. On

information and belief, BodyMedia has contributed to the design, development, manufacture,

marketing, and/or sale of at least the UP Move, UP3 and UP4 devices.

COUNT I
(Infringement of U.S. Patent No. 9,031,812)

17. Fitbit realleges paragraphs 1 through 16 as though fully set forth herein.

18. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to

infringe the ’812 patent in this judicial district and elsewhere in the United States, both literally

and under the doctrine of equivalents. Defendants have infringed and have continued to infringe

through the manufacture, use, offer for sale, sale, and/or importation of products, associated

software, and components, including, without limitation, the UP Move, UP24, UP2, UP3, and

UP4 and the UP App software interface.

19. On information and belief, at least from the service of this Complaint, Defendants

will contributorily infringe and/or actively induce infringement of the ’812 patent in violation of

35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’812

patent, with specific intent to contributorily infringe and/or to induce infringement, and with

knowledge or willful blindness that the induced acts would constitute patent infringement. On

information and belief, each of the UP Move, UP24, UP2, UP3, and UP4, each sold or offered

for sale by Defendants, is not a staple article of commerce, is a component of a patented

4
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 5Page
of 11 6PageID
of 125 #: 5

combination and material to practicing the invention in the claims of the ’812 patent, and has no

substantial non-infringing uses. These products are sold directly to customers and used by

customers to track and record physical activity in conjunction with the UP App in a manner that

infringes the ’812 patent.

20. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least

the following activities: designing and manufacturing the UP Move, UP24, UP2, UP3, and UP4

devices and their components specifically for sale and use in the United States, including

Delaware; selling and offering to sell these devices and their components in the United States or

importing these devices and their components into the United States, including Delaware; and

soliciting, encouraging, and enabling infringing activity in the United States, including

Delaware, through promotional and instructional materials, websites (including support

information, video instructions, tutorials, and frequently asked questions that direct customers to

use the devices in an infringing manner), activities relating to activity monitors or the UP Move,

UP24, UP2, UP3, and UP4 devices, and by providing access to and encouraging use of the UP

App and promoting the use of third-party applications.

21. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least

the following activities: designing and manufacturing at least the UP Move, UP3, and UP4

devices and their components specifically for sale and use in the United States, including

Delaware; and selling and offering to sell these devices and their components in the United

States or importing these devices and their components into the United States, including

Delaware.

5
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 6Page
of 11 7PageID
of 125 #: 6

22. Defendants’ acts of infringement of the ’812 patent have caused and will continue

to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive

relief and damages adequate to compensate Fitbit for such infringement.

23. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant

to 35 U.S.C. § 285.

24. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’

infringement of one or more claims of the ’812 patent.

COUNT II
(Infringement of U.S. Patent No. 8,909,543)

25. Fitbit realleges paragraphs 1 through 24 as though fully set forth herein.

26. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to

infringe the ’543 patent in this judicial district and elsewhere in the United States, both literally

and under the doctrine of equivalents. Defendants have infringed and have continued to infringe

through the manufacture, use, offer for sale, sale, and/or importation of products, associated

software, and components, including, without limitation, the UP Move activity tracker and the

UP App software interface.

27. On information and belief, at least from the service of this Complaint, Defendants

will contributorily infringe and/or actively induce infringement of the ’543 patent in violation of

35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’543

patent, with specific intent to contributorily infringe and/or to induce infringement, and with

knowledge or willful blindness that the induced acts would constitute patent infringement. On

information and belief, the UP Move and other activity trackers, each sold or offered for sale by

Defendants, is not a staple article of commerce, is a component of a patented combination and

material to practicing the invention in the claims of the ’543 patent, and has no substantial non-

6
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 7Page
of 11 8PageID
of 125 #: 7

infringing uses. These products are sold directly to customers and used by customers to track

and record physical activity in conjunction with the UP App in a manner that infringes the ’543

patent.

28. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least

the following activities: designing and manufacturing the UP Move and other activity tracker

devices and their components specifically for sale and use in the United States, including

Delaware; selling and offering to sell these devices and their components in the United States or

importing these devices and their components into the United States, including Delaware; and

soliciting, encouraging, and enabling infringing activity in the United States, including

Delaware, through promotional and instructional materials, websites (including support

information, video instructions, tutorials, and frequently asked questions that direct customers to

use the devices in an infringing manner), activities relating to activity monitors or the UP Move

devices, and by providing access to and encouraging use of the UP App and promoting the use of

third-party applications.

29. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least

the following activities: designing and manufacturing at least the UP Move and other activity

tracker devices and their components specifically for sale and use in the United States, including

Delaware; and selling and offering to sell these devices and their components in the United

States or importing these devices and their components into the United States, including

Delaware.

30. Defendants’ acts of infringement of the ’543 patent have caused and will continue

to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive

relief and damages adequate to compensate Fitbit for such infringement.

7
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-1 09/03/15
Filed 10/30/15
Page 8Page
of 11 9PageID
of 125 #: 8

31. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant

to 35 U.S.C. § 285.

32. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’

infringement of one or more claims of the ’543 patent.

COUNT III
(Infringement of U.S. Patent No. 9,042,971)

33. Fitbit realleges paragraphs 1 through 32 as though fully set forth herein.

34. In violation of 35 U.S.C. § 271, Defendants have infringed and continue to

infringe the ’971 patent in this judicial district and elsewhere in the United States, both literally

and under the doctrine of equivalents. Defendants have infringed and have continued to infringe

through the manufacture, use, offer for sale, sale, and/or importation of products, associated

software, and components, including, without limitation, the UP3 and UP4 activity trackers and

the UP App software interface.

35. On information and belief, at least from the service of this Complaint, Defendants

will contributorily infringe and/or actively induce infringement of the ’971 patent in violation of

35 U.S.C. § 271(b)-(c), with knowledge of or willful blindness to the existence of the ’971

patent, with specific intent to contributorily infringe and/or to induce infringement, and with

knowledge or willful blindness that the induced acts would constitute patent infringement. On

information and belief, each of the UP3 and UP4, each sold or offered for sale by Defendants, is

not a staple article of commerce, is a component of a patented combination and material to

practicing the invention in the claims of the ’971 patent, and has no substantial non-infringing

uses. These products are sold directly to customers and used by customers to track and record

physical activity in conjunction with the UP App in a manner that infringes the ’971 patent.

8
Case
Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 35-1
Filed 09/03/15
Filed 10/30/15
Page 9Page
of 1110
PageID
of 125#: 9

36. AliphCom’s indirect infringement will occur by AliphCom’s engaging in at least

the following activities: designing and manufacturing the UP3 and UP4 and other activity tracker

devices and their components specifically for sale and use in the United States, including

Delaware; selling and offering to sell these devices and their components in the United States or

importing these devices and their components into the United States, including Delaware; and

soliciting, encouraging, and enabling infringing activity in the United States, including

Delaware, through promotional and instructional materials, websites (including support

information, video instructions, tutorials, and frequently asked questions that direct customers to

use the devices in an infringing manner), activities relating to activity monitors or the UP3 and

UP4 devices, and by providing access to and encouraging use of the UP App and promoting the

use of third-party applications.

37. BodyMedia’s indirect infringement will occur by BodyMedia engaging in at least

the following activities: designing and manufacturing the UP3 and UP4 and other activity tracker

devices and their components specifically for sale and use in the United States, including

Delaware; and selling and offering to sell these devices and their components in the United

States or importing these devices and their components into the United States, including

Delaware.

38. Defendants’ acts of infringement of the ’971 patent have caused and will continue

to cause Fitbit substantial and irreparable injury, for which Fitbit is entitled to receive injunctive

relief and damages adequate to compensate Fitbit for such infringement.

39. This case is exceptional, and therefore, Fitbit is entitled to attorneys’ fees pursuant

to 35 U.S.C. § 285.

9
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-109/03/15
Filed 10/30/15
Page 10Page
of 1111
PageID
of 125#: 10

40. Fitbit is also entitled to damages under 35 U.S.C. § 284 for Defendants’

infringement of one or more claims of the ’971 patent.

JURY DEMAND

41. Pursuant to Rule 38(b) of the Federal Rules of Civil Procedure, Fitbit respectfully

requests a trial by jury on all issues.

REQUESTED RELIEF

Fitbit respectfully seeks the following relief:

a) The entry of judgment declaring that Defendants have infringed each of the

Patents-in-Suit;

b) An award of all available damages, including, but not limited to Fitbit’s lost

profits from Defendants’ infringement of the Patents-in-Suit, but in any event not less than a

reasonable royalty, together with pre-judgment and post-judgment interest;

c) An injunction restraining Defendants and their affiliates, subsidiaries, officers,

directors, agents, servants, employees, representatives, licensees, successors, assigns, and all

those acting for them and on their behalf, from further infringement, further inducements of

infringement, and further contributions to infringement of the Patents-in-Suit;

d) The entry of an order declaring that this is an exceptional case and awarding Fitbit

its costs, expenses, and reasonable attorney fees under 35 U.S.C. § 285 and all other applicable

statutes, rules, and common law; AND

e) An order awarding Fitbit any such other relief as the Court may deem just and

proper under the circumstances.

10
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1 Filed
35-109/03/15
Filed 10/30/15
Page 11Page
of 1112
PageID
of 125#: 11

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

/s/ Jack B. Blumenfeld

Jack B. Blumenfeld (#1014)


1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200

Attorneys for Plaintiff


OF COUNSEL:

Josh A. Krevitt
GIBSON, DUNN & CRUTCHER LLP
200 Park Avenue
New York, New York 10166
(212) 351-4000

Wayne M. Barsky
GIBSON, DUNN & CRUTCHER LLP
2029 Century Park East
Los Angeles, CA 90067-3026
(310) 552-8500

Frederick S. Chung
Stuart M. Rosenberg
Alison Watkins
GIBSON, DUNN & CRUTCHER LLP
1881 Page Mill Road
Palo Alto, CA 94304
(650) 849-5392

September 3, 2015

11
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 1Page
of 111
13PageID
of 125 #: 12

EXHIBIT A
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 2Page
of 111
14PageID
of 125 #: 13
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 3Page
of 111
15PageID
of 125 #: 14
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 4Page
of 111
16PageID
of 125 #: 15
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 5Page
of 111
17PageID
of 125 #: 16
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 6Page
of 111
18PageID
of 125 #: 17
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 7Page
of 111
19PageID
of 125 #: 18
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 8Page
of 111
20PageID
of 125 #: 19
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 9Page
of 111
21PageID
of 125 #: 20
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 10
Page
of 111
22 PageID
of 125 #: 21
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 11
Page
of 111
23 PageID
of 125 #: 22
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 12
Page
of 111
24 PageID
of 125 #: 23
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 13
Page
of 111
25 PageID
of 125 #: 24
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 14
Page
of 111
26 PageID
of 125 #: 25
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 15
Page
of 111
27 PageID
of 125 #: 26
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 16
Page
of 111
28 PageID
of 125 #: 27
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 17
Page
of 111
29 PageID
of 125 #: 28
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 18
Page
of 111
30 PageID
of 125 #: 29
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 19
Page
of 111
31 PageID
of 125 #: 30
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 20
Page
of 111
32 PageID
of 125 #: 31
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 21
Page
of 111
33 PageID
of 125 #: 32
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 22
Page
of 111
34 PageID
of 125 #: 33
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 23
Page
of 111
35 PageID
of 125 #: 34
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 24
Page
of 111
36 PageID
of 125 #: 35
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 25
Page
of 111
37 PageID
of 125 #: 36
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 26
Page
of 111
38 PageID
of 125 #: 37
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 27
Page
of 111
39 PageID
of 125 #: 38
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 28
Page
of 111
40 PageID
of 125 #: 39
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 29
Page
of 111
41 PageID
of 125 #: 40
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 30
Page
of 111
42 PageID
of 125 #: 41
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 31
Page
of 111
43 PageID
of 125 #: 42
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 32
Page
of 111
44 PageID
of 125 #: 43

EXHIBIT B
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 33
Page
of 111
45 PageID
of 125 #: 44
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 34
Page
of 111
46 PageID
of 125 #: 45
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 35
Page
of 111
47 PageID
of 125 #: 46
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 36
Page
of 111
48 PageID
of 125 #: 47
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 37
Page
of 111
49 PageID
of 125 #: 48
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 38
Page
of 111
50 PageID
of 125 #: 49
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 39
Page
of 111
51 PageID
of 125 #: 50
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 40
Page
of 111
52 PageID
of 125 #: 51
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 41
Page
of 111
53 PageID
of 125 #: 52
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 42
Page
of 111
54 PageID
of 125 #: 53
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 43
Page
of 111
55 PageID
of 125 #: 54
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 44
Page
of 111
56 PageID
of 125 #: 55
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 45
Page
of 111
57 PageID
of 125 #: 56
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 46
Page
of 111
58 PageID
of 125 #: 57
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 47
Page
of 111
59 PageID
of 125 #: 58
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 48
Page
of 111
60 PageID
of 125 #: 59
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 49
Page
of 111
61 PageID
of 125 #: 60
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 50
Page
of 111
62 PageID
of 125 #: 61
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 51
Page
of 111
63 PageID
of 125 #: 62
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 52
Page
of 111
64 PageID
of 125 #: 63
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 53
Page
of 111
65 PageID
of 125 #: 64
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 54
Page
of 111
66 PageID
of 125 #: 65
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 55
Page
of 111
67 PageID
of 125 #: 66
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 56
Page
of 111
68 PageID
of 125 #: 67
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 57
Page
of 111
69 PageID
of 125 #: 68
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 58
Page
of 111
70 PageID
of 125 #: 69
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 59
Page
of 111
71 PageID
of 125 #: 70
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 60
Page
of 111
72 PageID
of 125 #: 71
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 61
Page
of 111
73 PageID
of 125 #: 72
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 62
Page
of 111
74 PageID
of 125 #: 73
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 63
Page
of 111
75 PageID
of 125 #: 74
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 64
Page
of 111
76 PageID
of 125 #: 75
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 65
Page
of 111
77 PageID
of 125 #: 76
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 66
Page
of 111
78 PageID
of 125 #: 77
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 67
Page
of 111
79 PageID
of 125 #: 78
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 68
Page
of 111
80 PageID
of 125 #: 79
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 69
Page
of 111
81 PageID
of 125 #: 80

EXHIBIT C
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 70
Page
of 111
82 PageID
of 125 #: 81
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 71
Page
of 111
83 PageID
of 125 #: 82
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 72
Page
of 111
84 PageID
of 125 #: 83
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 73
Page
of 111
85 PageID
of 125 #: 84
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 74
Page
of 111
86 PageID
of 125 #: 85
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 75
Page
of 111
87 PageID
of 125 #: 86
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 76
Page
of 111
88 PageID
of 125 #: 87
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 77
Page
of 111
89 PageID
of 125 #: 88
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 78
Page
of 111
90 PageID
of 125 #: 89
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 79
Page
of 111
91 PageID
of 125 #: 90
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 80
Page
of 111
92 PageID
of 125 #: 91
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 81
Page
of 111
93 PageID
of 125 #: 92
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 82
Page
of 111
94 PageID
of 125 #: 93
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 83
Page
of 111
95 PageID
of 125 #: 94
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 84
Page
of 111
96 PageID
of 125 #: 95
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 85
Page
of 111
97 PageID
of 125 #: 96
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 86
Page
of 111
98 PageID
of 125 #: 97
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 87
Page
of 111
99 PageID
of 125 #: 98
Case Case
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 88
Page
of 111
100PageID
of 125 #: 99
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 89
Page
of 111
101PageID
of 125 #: 100
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 90
Page
of 111
102PageID
of 125 #: 101
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 91
Page
of 111
103PageID
of 125 #: 102
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 92
Page
of 111
104PageID
of 125 #: 103
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 93
Page
of 111
105PageID
of 125 #: 104
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 94
Page
of 111
106PageID
of 125 #: 105
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 95
Page
of 111
107PageID
of 125 #: 106
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 96
Page
of 111
108PageID
of 125 #: 107
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 97
Page
of 111
109PageID
of 125 #: 108
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 98
Page
of 111
110PageID
of 125 #: 109
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-1 09/03/15
Filed 10/30/15
Page 99
Page
of 111
111PageID
of 125 #: 110
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 100
Page
of 111
112PageID
of 125 #: 111
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 101
Page
of 111
113PageID
of 125 #: 112
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 102
Page
of 111
114PageID
of 125 #: 113
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 103
Page
of 111
115PageID
of 125 #: 114
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 104
Page
of 111
116PageID
of 125 #: 115
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 105
Page
of 111
117PageID
of 125 #: 116
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 106
Page
of 111
118PageID
of 125 #: 117
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 107
Page
of 111
119PageID
of 125 #: 118
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 108
Page
of 111
120PageID
of 125 #: 119
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 109
Page
of 111
121PageID
of 125 #: 120
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 110
Page
of 111
122PageID
of 125 #: 121
Case 1:15-cv-00775-UNA
Case 5:15-cv-04073-EJD
Document
Document
1-1 Filed
35-109/03/15
Filed 10/30/15
Page 111
Page
of 111
123PageID
of 125 #: 122
CaseCase
1:15-cv-00775-UNA
5:15-cv-04073-EJD
Document
Document
1-2 35-1
Filed Filed
09/03/15
10/30/15
Page Page
1 of 2124
PageID
of 125
#: 123
-6 5HY CIVIL COVER SHEET
7KH-6FLYLOFRYHUVKHHWDQGWKHLQIRUPDWLRQFRQWDLQHGKHUHLQQHLWKHUUHSODFHQRUVXSSOHPHQWWKHILOLQJDQGVHUYLFHRISOHDGLQJVRURWKHUSDSHUVDVUHTXLUHGE\ODZH[FHSWDV
SURYLGHGE\ORFDOUXOHVRIFRXUW7KLVIRUPDSSURYHGE\WKH-XGLFLDO&RQIHUHQFHRIWKH8QLWHG6WDWHVLQ6HSWHPEHULVUHTXLUHGIRUWKHXVHRIWKH&OHUNRI&RXUWIRUWKH
SXUSRVHRILQLWLDWLQJWKHFLYLOGRFNHWVKHHW(SEE INSTRUCTIONS ON NEXT PAGE OF THIS FORM.)

I. (a) PLAINTIFFS DEFENDANTS


FITBIT, INC. ALIPHCOM d/b/a JAWBONE and BODYMEDIA, INC.

(b)&RXQW\RI5HVLGHQFHRI)LUVW/LVWHG3ODLQWLII &RXQW\RI5HVLGHQFHRI)LUVW/LVWHG'HIHQGDQW
(EXCEPT IN U.S. PLAINTIFF CASES) (IN U.S. PLAINTIFF CASES ONLY)
127( ,1/$1'&21'(01$7,21&$6(686(7+(/2&$7,212)
7+(75$&72)/$1',192/9('

(c)$WWRUQH\V(Firm Name, Address, and Telephone Number) $WWRUQH\V(If Known)
Jack B. Blumenfeld 302-658-9200
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street; P.O. Box 1347; Wilmington, DE 19899

II. BASIS OF JURISDICTION(Place an “X” in One Box Only) III. CITIZENSHIP OF PRINCIPAL PARTIES (Place an “X” in One Box for Plaintiff
(For Diversity Cases Only) and One Box for Defendant)
u  86*RYHUQPHQW u  )HGHUDO4XHVWLRQ PTF DEF PTF DEF
3ODLQWLII (U.S. Government Not a Party) &LWL]HQRI7KLV6WDWH u  u  ,QFRUSRUDWHGor3ULQFLSDO3ODFH u  u 
RI%XVLQHVV,Q7KLV6WDWH

u  86*RYHUQPHQW u  'LYHUVLW\ &LWL]HQRI$QRWKHU6WDWH u  u  ,QFRUSRUDWHGand3ULQFLSDO3ODFH u  u 


'HIHQGDQW (Indicate Citizenship of Parties in Item III) RI%XVLQHVV,Q$QRWKHU6WDWH

&LWL]HQRU6XEMHFWRID u  u  )RUHLJQ1DWLRQ u  u 
)RUHLJQ&RXQWU\
IV. NATURE OF SUIT(Place an “X” in One Box Only)
CONTRACT TORTS FORFEITURE/PENALTY BANKRUPTCY OTHER STATUTES
u ,QVXUDQFH  PERSONAL INJURY PERSONAL INJURY u 'UXJ5HODWHG6HL]XUH u $SSHDO86& u )DOVH&ODLPV$FW
u 0DULQH u $LUSODQH u 3HUVRQDO,QMXU\ RI3URSHUW\86& u :LWKGUDZDO u 6WDWH5HDSSRUWLRQPHQW
u 0LOOHU$FW u $LUSODQH3URGXFW 3URGXFW/LDELOLW\ u 2WKHU 86& u $QWLWUXVW
u 1HJRWLDEOH,QVWUXPHQW /LDELOLW\ u +HDOWK&DUH u %DQNVDQG%DQNLQJ
u 5HFRYHU\RI2YHUSD\PHQW u $VVDXOW/LEHO 3KDUPDFHXWLFDO PROPERTY RIGHTS u &RPPHUFH
 (QIRUFHPHQWRI-XGJPHQW 6ODQGHU 3HUVRQDO,QMXU\ u &RS\ULJKWV u 'HSRUWDWLRQ
u 0HGLFDUH$FW u )HGHUDO(PSOR\HUV¶ 3URGXFW/LDELOLW\ u 3DWHQW u 5DFNHWHHU,QIOXHQFHGDQG
u 5HFRYHU\RI'HIDXOWHG /LDELOLW\ u $VEHVWRV3HUVRQDO u 7UDGHPDUN &RUUXSW2UJDQL]DWLRQV
6WXGHQW/RDQV u 0DULQH ,QMXU\3URGXFW u &RQVXPHU&UHGLW
 ([FOXGHV9HWHUDQV u 0DULQH3URGXFW /LDELOLW\ LABOR SOCIAL SECURITY u &DEOH6DW79
u 5HFRYHU\RI2YHUSD\PHQW /LDELOLW\  PERSONAL PROPERTY u )DLU/DERU6WDQGDUGV u +,$ II u 6HFXULWLHV&RPPRGLWLHV
RI9HWHUDQ¶V%HQHILWV u 0RWRU9HKLFOH u 2WKHU)UDXG $FW u %ODFN/XQJ  ([FKDQJH
u 6WRFNKROGHUV¶6XLWV u 0RWRU9HKLFOH u 7UXWKLQ/HQGLQJ u /DERU0DQDJHPHQW u ',:&',::  J u 2WKHU6WDWXWRU\$FWLRQV
u 2WKHU&RQWUDFW 3URGXFW/LDELOLW\ u 2WKHU3HUVRQDO 5HODWLRQV u 66,'7LWOH;9, u $JULFXOWXUDO$FWV
u &RQWUDFW3URGXFW/LDELOLW\ u 2WKHU3HUVRQDO 3URSHUW\'DPDJH u 5DLOZD\/DERU$FW u 56,  J u (QYLURQPHQWDO0DWWHUV
u )UDQFKLVH ,QMXU\ u 3URSHUW\'DPDJH u )DPLO\DQG0HGLFDO u )UHHGRPRI,QIRUPDWLRQ
u 3HUVRQDO,QMXU\ 3URGXFW/LDELOLW\ /HDYH$FW $FW
0HGLFDO0DOSUDFWLFH u 2WKHU/DERU/LWLJDWLRQ u $UELWUDWLRQ
REAL PROPERTY CIVIL RIGHTS PRISONER PETITIONS u (PSOR\HH5HWLUHPHQW FEDERAL TAX SUITS u $GPLQLVWUDWLYH3URFHGXUH
u /DQG&RQGHPQDWLRQ u 2WKHU&LYLO5LJKWV Habeas Corpus: ,QFRPH6HFXULW\$FW u 7D[HV 863ODLQWLII $FW5HYLHZRU$SSHDORI
u )RUHFORVXUH u 9RWLQJ u $OLHQ'HWDLQHH RU'HIHQGDQW $JHQF\'HFLVLRQ
u 5HQW/HDVH (MHFWPHQW u (PSOR\PHQW u 0RWLRQVWR9DFDWH u ,56²7KLUG3DUW\ u &RQVWLWXWLRQDOLW\RI
u 7RUWVWR/DQG u +RXVLQJ 6HQWHQFH 86& 6WDWH6WDWXWHV
u 7RUW3URGXFW/LDELOLW\ $FFRPPRGDWLRQV u *HQHUDO
u $OO2WKHU5HDO3URSHUW\ u $PHUZ'LVDELOLWLHV u 'HDWK3HQDOW\ IMMIGRATION
(PSOR\PHQW Other: u 1DWXUDOL]DWLRQ$SSOLFDWLRQ
u $PHUZ'LVDELOLWLHV u 0DQGDPXV 2WKHU u 2WKHU,PPLJUDWLRQ
2WKHU u &LYLO5LJKWV $FWLRQV
u (GXFDWLRQ u 3ULVRQ&RQGLWLRQ
u &LYLO'HWDLQHH
&RQGLWLRQVRI
&RQILQHPHQW
V. ORIGIN(Place an “X” in One Box Only)
u  2ULJLQDO u  5HPRYHGIURP u  5HPDQGHGIURP u  5HLQVWDWHGRU u  7UDQVIHUUHGIURP u  0XOWLGLVWULFW
3URFHHGLQJ 6WDWH&RXUW $SSHOODWH&RXUW 5HRSHQHG $QRWKHU'LVWULFW /LWLJDWLRQ
(specify)
&LWHWKH86&LYLO6WDWXWHXQGHUZKLFK\RXDUHILOLQJ(Do not cite jurisdictional statutes unless diversity)
35 U.S.C. § 271
VI. CAUSE OF ACTION %ULHIGHVFULSWLRQRIFDXVH
Patent Infringement
VII. REQUESTED IN u &+(&.,)7+,6,6$CLASS ACTION DEMAND $ &+(&.<(6RQO\LIGHPDQGHGLQFRPSODLQW
COMPLAINT: 81'(558/()5&Y3 JURY DEMAND: u <HV u 1R
VIII. RELATED CASE(S)
(See instructions):
IF ANY -8'*( '2&.(7180%(5
'$7( 6,*1$785(2)$77251(<2)5(&25'
09/03/2015 /s/ Jack B. Blumenfeld
FOR OFFICE USE ONLY

5(&(,37 $02817 $33/<,1*,)3 -8'*( 0$*-8'*(


CaseCase
1:15-cv-00775-UNA
-65HYHUVH 5HY 5:15-cv-04073-EJD
Document
Document
1-2 35-1
Filed Filed
09/03/15
10/30/15
Page Page
2 of 2125
PageID
of 125
#: 124
INSTRUCTIONS FOR ATTORNEYS COMPLETING CIVIL COVER SHEET FORM JS 44
$XWKRULW\)RU&LYLO&RYHU6KHHW

7KH-6FLYLOFRYHUVKHHWDQGWKHLQIRUPDWLRQFRQWDLQHGKHUHLQQHLWKHUUHSODFHVQRUVXSSOHPHQWVWKHILOLQJVDQGVHUYLFHRISOHDGLQJRURWKHUSDSHUVDV
UHTXLUHGE\ODZH[FHSWDVSURYLGHGE\ORFDOUXOHVRIFRXUW7KLVIRUPDSSURYHGE\WKH-XGLFLDO&RQIHUHQFHRIWKH8QLWHG6WDWHVLQ6HSWHPEHULV
UHTXLUHGIRUWKHXVHRIWKH&OHUNRI&RXUWIRUWKHSXUSRVHRILQLWLDWLQJWKHFLYLOGRFNHWVKHHW&RQVHTXHQWO\DFLYLOFRYHUVKHHWLVVXEPLWWHGWRWKH&OHUNRI
&RXUWIRUHDFKFLYLOFRPSODLQWILOHG7KHDWWRUQH\ILOLQJDFDVHVKRXOGFRPSOHWHWKHIRUPDVIROORZV

I.(a) Plaintiffs-Defendants.(QWHUQDPHV ODVWILUVWPLGGOHLQLWLDO RISODLQWLIIDQGGHIHQGDQW,IWKHSODLQWLIIRUGHIHQGDQWLVDJRYHUQPHQWDJHQF\XVH


RQO\WKHIXOOQDPHRUVWDQGDUGDEEUHYLDWLRQV,IWKHSODLQWLIIRUGHIHQGDQWLVDQRIILFLDOZLWKLQDJRYHUQPHQWDJHQF\LGHQWLI\ILUVWWKHDJHQF\DQG
WKHQWKHRIILFLDOJLYLQJERWKQDPHDQGWLWOH
(b) County of Residence.)RUHDFKFLYLOFDVHILOHGH[FHSW86SODLQWLIIFDVHVHQWHUWKHQDPHRIWKHFRXQW\ZKHUHWKHILUVWOLVWHGSODLQWLIIUHVLGHVDWWKH
WLPHRIILOLQJ,Q86SODLQWLIIFDVHVHQWHUWKHQDPHRIWKHFRXQW\LQZKLFKWKHILUVWOLVWHGGHIHQGDQWUHVLGHVDWWKHWLPHRIILOLQJ 127(,QODQG
FRQGHPQDWLRQFDVHVWKHFRXQW\RIUHVLGHQFHRIWKHGHIHQGDQWLVWKHORFDWLRQRIWKHWUDFWRIODQGLQYROYHG
(c) Attorneys.(QWHUWKHILUPQDPHDGGUHVVWHOHSKRQHQXPEHUDQGDWWRUQH\RIUHFRUG,IWKHUHDUHVHYHUDODWWRUQH\VOLVWWKHPRQDQDWWDFKPHQWQRWLQJ
LQWKLVVHFWLRQ VHHDWWDFKPHQW 

II. Jurisdiction.7KHEDVLVRIMXULVGLFWLRQLVVHWIRUWKXQGHU5XOH D )5&Y3ZKLFKUHTXLUHVWKDWMXULVGLFWLRQVEHVKRZQLQSOHDGLQJV3ODFHDQ;


LQRQHRIWKHER[HV,IWKHUHLVPRUHWKDQRQHEDVLVRIMXULVGLFWLRQSUHFHGHQFHLVJLYHQLQWKHRUGHUVKRZQEHORZ
8QLWHG6WDWHVSODLQWLII  -XULVGLFWLRQEDVHGRQ86&DQG6XLWVE\DJHQFLHVDQGRIILFHUVRIWKH8QLWHG6WDWHVDUHLQFOXGHGKHUH
8QLWHG6WDWHVGHIHQGDQW  :KHQWKHSODLQWLIILVVXLQJWKH8QLWHG6WDWHVLWVRIILFHUVRUDJHQFLHVSODFHDQ;LQWKLVER[
)HGHUDOTXHVWLRQ  7KLVUHIHUVWRVXLWVXQGHU86&ZKHUHMXULVGLFWLRQDULVHVXQGHUWKH&RQVWLWXWLRQRIWKH8QLWHG6WDWHVDQDPHQGPHQW
WRWKH&RQVWLWXWLRQDQDFWRI&RQJUHVVRUDWUHDW\RIWKH8QLWHG6WDWHV,QFDVHVZKHUHWKH86LVDSDUW\WKH86SODLQWLIIRUGHIHQGDQWFRGHWDNHV
SUHFHGHQFHDQGER[RUVKRXOGEHPDUNHG
'LYHUVLW\RIFLWL]HQVKLS  7KLVUHIHUVWRVXLWVXQGHU86&ZKHUHSDUWLHVDUHFLWL]HQVRIGLIIHUHQWVWDWHV:KHQ%R[LVFKHFNHGWKH
FLWL]HQVKLSRIWKHGLIIHUHQWSDUWLHVPXVWEHFKHFNHG. 6HH6HFWLRQ,,,EHORZ; NOTE: federal question actions take precedence over diversity
cases.

III. Residence (citizenship) of Principal Parties.7KLVVHFWLRQRIWKH-6LVWREHFRPSOHWHGLIGLYHUVLW\RIFLWL]HQVKLSZDVLQGLFDWHGDERYH0DUNWKLV


VHFWLRQIRUHDFKSULQFLSDOSDUW\

IV. Nature of Suit.3ODFHDQ;LQWKHDSSURSULDWHER[,IWKHQDWXUHRIVXLWFDQQRWEHGHWHUPLQHGEHVXUHWKHFDXVHRIDFWLRQLQ6HFWLRQ9,EHORZLV


VXIILFLHQWWRHQDEOHWKHGHSXW\FOHUNRUWKHVWDWLVWLFDOFOHUN V LQWKH$GPLQLVWUDWLYH2IILFHWRGHWHUPLQHWKHQDWXUHRIVXLW,IWKHFDXVHILWVPRUHWKDQ
RQHQDWXUHRIVXLWVHOHFWWKHPRVWGHILQLWLYH

V. Origin.3ODFHDQ;LQRQHRIWKHVL[ER[HV
2ULJLQDO3URFHHGLQJV  &DVHVZKLFKRULJLQDWHLQWKH8QLWHG6WDWHVGLVWULFWFRXUWV
5HPRYHGIURP6WDWH&RXUW  3URFHHGLQJVLQLWLDWHGLQVWDWHFRXUWVPD\EHUHPRYHGWRWKHGLVWULFWFRXUWVXQGHU7LWOH86&6HFWLRQ
:KHQWKHSHWLWLRQIRUUHPRYDOLVJUDQWHGFKHFNWKLVER[
5HPDQGHGIURP$SSHOODWH&RXUW  &KHFNWKLVER[IRUFDVHVUHPDQGHGWRWKHGLVWULFWFRXUWIRUIXUWKHUDFWLRQ8VHWKHGDWHRIUHPDQGDVWKHILOLQJ
GDWH
5HLQVWDWHGRU5HRSHQHG  &KHFNWKLVER[IRUFDVHVUHLQVWDWHGRUUHRSHQHGLQWKHGLVWULFWFRXUW8VHWKHUHRSHQLQJGDWHDVWKHILOLQJGDWH
7UDQVIHUUHGIURP$QRWKHU'LVWULFW  )RUFDVHVWUDQVIHUUHGXQGHU7LWOH86&6HFWLRQ D 'RQRWXVHWKLVIRUZLWKLQGLVWULFWWUDQVIHUVRU
PXOWLGLVWULFWOLWLJDWLRQWUDQVIHUV
0XOWLGLVWULFW/LWLJDWLRQ  &KHFNWKLVER[ZKHQDPXOWLGLVWULFWFDVHLVWUDQVIHUUHGLQWRWKHGLVWULFWXQGHUDXWKRULW\RI7LWOH86&6HFWLRQ
:KHQWKLVER[LVFKHFNHGGRQRWFKHFN  DERYH

VI. Cause of Action.5HSRUWWKHFLYLOVWDWXWHGLUHFWO\UHODWHGWRWKHFDXVHRIDFWLRQDQGJLYHDEULHIGHVFULSWLRQRIWKHFDXVHDo not cite jurisdictional


statutes unless diversity. ([DPSOH86&LYLO6WDWXWH86&%ULHI'HVFULSWLRQ8QDXWKRUL]HGUHFHSWLRQRIFDEOHVHUYLFH

VII. Requested in Complaint.&ODVV$FWLRQ3ODFHDQ;LQWKLVER[LI\RXDUHILOLQJDFODVVDFWLRQXQGHU5XOH)5&Y3


'HPDQG,QWKLVVSDFHHQWHUWKHDFWXDOGROODUDPRXQWEHLQJGHPDQGHGRULQGLFDWHRWKHUGHPDQGVXFKDVDSUHOLPLQDU\LQMXQFWLRQ
-XU\'HPDQG&KHFNWKHDSSURSULDWHER[WRLQGLFDWHZKHWKHURUQRWDMXU\LVEHLQJGHPDQGHG

VIII. Related Cases.7KLVVHFWLRQRIWKH-6LVXVHGWRUHIHUHQFHUHODWHGSHQGLQJFDVHVLIDQ\,IWKHUHDUHUHODWHGSHQGLQJFDVHVLQVHUWWKHGRFNHW


QXPEHUVDQGWKHFRUUHVSRQGLQJMXGJHQDPHVIRUVXFKFDVHV

Date and Attorney Signature.'DWHDQGVLJQWKHFLYLOFRYHUVKHHW

Potrebbero piacerti anche